Company / Tangible Book Value per Share
Decoy Therapeutics Inc. Tangible Book Value per Share History
FY2016-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$21.40
FY2022
5-year range
-$4.99 / $21.40
FY2018-FY2022
Trend
+3732.6%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Tangible Book Value per Share changed +3733% YoY in FY2022, a notable deviation from the 6-year average annual change of +806%.
Based on SEC 10-K filings.
21.40 in FY2022 with a 5-year CAGR of +31.2%.
Improved from $0.38 to $21.40 over the past 2 years.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +31.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- Decoy Therapeutics Inc.'s tangible book value per share has grown for 3 consecutive years.
- In FY2022, tangible book value per share increased 3732.6% year-over-year.
- Lowest tangible book value per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.27 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $21.40 | +3732.6% |
| FY2021 | $0.56 | +46.9% |
| FY2020 | $0.38 | +107.6% |
| FY2019 | -$4.99 | -404.9% |
| FY2018 | $1.64 | -70.2% |
| FY2017 | $5.50 | +1423.3% |
| FY2016 | -$0.42 | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026